Found: 13
Select item for more details and to access through your institution.
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 9, p. 2365, doi. 10.1007/s00432-019-02971-7
- By:
- Publication type:
- Article
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1259, doi. 10.3390/cancers12051259
- By:
- Publication type:
- Article
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.712053
- By:
- Publication type:
- Article
Pazopanib and pancreatic toxicity: a case report.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1154-4
- By:
- Publication type:
- Article
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
- Published in:
- Bioengineering (Basel), 2019, v. 6, n. 1, p. 1, doi. 10.3390/bioengineering6010011
- By:
- Publication type:
- Article
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 318, doi. 10.1016/j.clcc.2021.07.003
- By:
- Publication type:
- Article
Bevacizumab in Association With de Gramont 5-Fluorouracil/Folinic Acid in Patients With Oxaliplatin-, Irinotecan-, and Cetuximab-Refractory Colorectal Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 20, p. 4849, doi. 10.1002/cncr.24540
- By:
- Publication type:
- Article
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib.
- Published in:
- Oncologist, 2010, v. 15, n. 1, p. 85, doi. 10.1634/theoncologist.2009-0143
- By:
- Publication type:
- Article
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practice.
- Published in:
- Oncology Letters, 2018, v. 16, n. 6, p. 7195, doi. 10.3892/ol.2018.9561
- By:
- Publication type:
- Article
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2159, doi. 10.2147/OTT.S194745
- By:
- Publication type:
- Article
Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1074-7
- By:
- Publication type:
- Article
Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen.
- Published in:
- Oncology Reports, 2018, v. 40, n. 2, p. 803, doi. 10.3892/or.2018.6475
- By:
- Publication type:
- Article